AbbVie (ABBV) to Acquire Stemcentrx in ~$5.8B Cash and Stock Deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. AMD
7. USO
8. META
9. AMC
10. MSFT

Go back to AbbVie (ABBV) to Acquire Stemcentrx in ~$5.8B Cash and Stock Deal
AbbVie (NYSE: ABBV) Delayed: 266.09 +2.13 (0.81%)
Previous Close $263.96    52 Week High $68.12 
Open $263.07    52 Week Low $50.71 
Day High $266.60    P/E 57.72 
Day Low $261.23    EPS $4.61 
Volume 1,432,302